Technical Analysis for IMNM - Immunome, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 29.72 | -2.24% | -0.68 |
IMNM closed down 2.24 percent on Monday, April 12, 2021, on 14 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | N/A | Flat | Down |
Historical IMNM trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 50 DMA | Bearish | 0.00% | |
1,2,3 Pullback Bullish | Bullish Swing Setup | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Multiple of Ten Bearish | Other | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
1,2,3 Pullback Bullish | Bullish Swing Setup | -2.24% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | -2.24% | |
Narrow Range Bar | Range Contraction | -2.24% | |
Multiple of Ten Bullish | Other | -2.24% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
50 DMA Support | about 8 hours ago |
Down 2 % | about 8 hours ago |
Down 1% | about 8 hours ago |
Fell Below Previous Day's Low | about 8 hours ago |
Up 2% | 3 days ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
Immunome Inc., a biotechnology company, discovers, develops, and commercializes highly targeted and native human cancer antibodies against universal cancer antigens. Its RealMAb technology enables the discovery of novel antigens and the cognate native human antibodies that target antigens; and ScreenMab multiplex functional screening technology identifies monoclonal antibodies that have exquisite for tumor neoantigens. The company was founded in 2006 and is based in Exton, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Clinical Medicine Immunology Immune System Antibodies Monoclonal Antibody Monoclonal Antibodies Cancer Immunotherapy Antibody Multiplex Tumor Glycoproteins Antigen
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Clinical Medicine Immunology Immune System Antibodies Monoclonal Antibody Monoclonal Antibodies Cancer Immunotherapy Antibody Multiplex Tumor Glycoproteins Antigen
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 63.78 |
52 Week Low | 9.27 |
Average Volume | 322,908 |
200-Day Moving Average | 0.00 |
50-Day Moving Average | 29.84 |
20-Day Moving Average | 31.96 |
10-Day Moving Average | 31.14 |
Average True Range | 3.15 |
ADX | 32.26 |
+DI | 26.70 |
-DI | 17.80 |
Chandelier Exit (Long, 3 ATRs ) | 32.22 |
Chandelier Exit (Short, 3 ATRs ) | 37.63 |
Upper Bollinger Band | 36.24 |
Lower Bollinger Band | 27.67 |
Percent B (%b) | 0.24 |
BandWidth | 26.81 |
MACD Line | 0.10 |
MACD Signal Line | 0.65 |
MACD Histogram | -0.5482 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 31.16 | ||||
Resistance 3 (R3) | 31.25 | 30.85 | 30.92 | ||
Resistance 2 (R2) | 30.85 | 30.49 | 30.81 | 30.84 | |
Resistance 1 (R1) | 30.29 | 30.26 | 30.09 | 30.20 | 30.76 |
Pivot Point | 29.89 | 29.89 | 29.80 | 29.85 | 29.89 |
Support 1 (S1) | 29.33 | 29.53 | 29.13 | 29.24 | 28.68 |
Support 2 (S2) | 28.93 | 29.30 | 28.89 | 28.60 | |
Support 3 (S3) | 28.37 | 28.93 | 28.52 | ||
Support 4 (S4) | 28.28 |